Affiliation:
1. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Moscow, Russian Federation
Abstract
Background:
Targeting of drugs to the subcellular compartments represents one of the modern
trends in molecular pharmacology. The approach for targeting mitochondria was developed nearly
50 years ago, but only in the last decade has it started to become widely used for delivering drugs. A
number of pathologies are associated with mitochondrial dysfunction, including cardiovascular, neurological,
inflammatory and metabolic conditions.
Objective:
This mini-review aims to highlight the role of mitochondria in pathophysiological conditions
and diseases, to classify and summarize our knowledge about targeting mitochondria and to review the
most important preclinical and clinical data relating to the antioxidant lipophilic cations MitoQ and
SkQ1.
Methods:
This is a review of available information in the PubMed and Clinical Trials databases (US
National Library of Medicine) with no limiting period.
Results and Conclusion:
Mitochondria play an important role in the pathogenesis of many diseases and
possibly in aging. Both MitoQ and SkQ1 have shown many beneficial features in animal models and in
a few completed clinical trials. More clinical trials and research efforts are needed to understand the
signaling pathways influenced by these compounds. The antioxidant lipophilic cations have great potential
for the treatment of a wide range of pathologies.
Funder
Russian Foundation for Basic Research
Russian Science Foundation
Publisher
Bentham Science Publishers Ltd.
Subject
General Health Professions
Reference138 articles.
1. Davis S.S.; Biomedical applications of nanotechnology--implications for drug targeting and gene therapy. Trends Biotechnol 1997,15(6),217-224
2. Keservani R.K.; Sharma A.K.; Kesharwani R.K.; Drug
Delivery Approaches and Nanosystems, Volume 2: Drug Targeting
Aspects of Nanotechnology. CRC Press: 2017
3. Burns R.J.; Smith R.A.; Murphy M.P.; Synthesis and characterization of thiobutyltriphenylphosphonium bromide, a novel thiol reagent targeted to the mitochondrial matrix. Arch Biochem Biophys 1995,322(1),60-68
4. Wallace D.C.; Fan W.; Energetics, epigenetics, mitochondrial genetics. Mitochondrion 2010,10(1),12-31
5. Nicholls D.G.; Bernson V.S.; Heaton G.M.; The identification of the component in the inner membrane of brown adipose tissue mitochondria responsible for regulating energy dissipation. Experientia Suppl 1978,32,89-93
Cited by
137 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献